ArticleDrug delivery and translational research2026
Fractional microporation-guided delivery of nanoencapsulated drugs for enhanced cutaneous and follicular absorption: a comparison of ablative laser and radiofrequency microneedling.
Article in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Radiofrequency Microneedling-Mediated Enhancement in Percutaneous Delivery of Topical Triamcinolone Acetonide: An In Vivo Quantitative Study.Life (Basel, Switzerland) · 2026Article
- Transdermal needle-free drug delivery approaches and activation mechanism.Materials today. Bio · 2026Review
- Liposome drug delivery strategies: state-of-the-art for combating bacterial biofilms.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The use of fractional microporation to disrupt superficial skin is an effective approach to enhance drug absorption. This study analyzed and compared the effectiveness of fractional Er:YAG laser and radiofrequency microneedling (RM) in promoting skin penetration and hair follicle (HF) targeting of free or nanoencapsulated minoxidil and minocycline. Porcine skin delivery, with or without laser (3, 6, and 7 mJ) and RM (6.1, 10.2, and 20.4 mJ with a penetration depth of 0.5 or 1.0 mm), was investigated using in vitro permeation test (IVPT). The in vitro and in vivo antibacterial activity of the microporation-assisted minocycline-loaded nanocarriers was also conducted. The skin deposition and flux of free minoxidil were increased by 3- and 56-fold, respectively, with laser treatment at 7 mJ. The laser enhanced the deposition and flux of free minocycline by 25- and 40-fold compared to the untreated control, respectively. RM elevated the drug flux by 5‒18-fold compared to passive absorption. However, this enhancement effect was not observed in skin deposition. Nanostructured lipid carriers (NLC) and liposomes, with sizes of 81 and 76 nm, were produced and entrapped approximately 80% of the drugs, respectively. Microporation increased skin delivery of nanoencapsulated drugs, though this enhancement was less pronounced than that of the free drugs. Biodistribution observed through confocal microscopy showed that microporation increased the penetration depth of lipid-based nanocarriers into the dermis compared to passive diffusion. The nanocarriers were primarily distributed into the microchannels and transported into the surrounding dermal tissue. Minocycline uptake in HF increased from 0.03 to 0.16 and 0.20 nmol/cm
Indexed as
Identifiers
40439860What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.